Packaged Foods
Compare Stocks
5 / 10Stock Comparison
SOWG vs HIMS vs SMPL vs NOMD vs JBSS
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Equipment & Services
Packaged Foods
Packaged Foods
Packaged Foods
SOWG vs HIMS vs SMPL vs NOMD vs JBSS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Packaged Foods | Medical - Equipment & Services | Packaged Foods | Packaged Foods | Packaged Foods |
| Market Cap | $1M | $6.63B | $1.24B | $1.44B | $913M |
| Revenue (TTM) | $0.00 | $2.35B | $1.45B | $3.03B | $1.14B |
| Net Income (TTM) | $-41M | $128M | $91M | $137M | $70M |
| Gross Margin | — | 69.7% | 34.0% | 27.1% | 19.1% |
| Operating Margin | — | 4.6% | 14.4% | 10.7% | 8.9% |
| Forward P/E | — | 58.3x | 7.4x | 6.2x | 11.9x |
| Total Debt | $2M | $1.12B | $304M | $2.29B | $102M |
| Cash & Equiv. | $1M | $229M | $98M | $325M | $585K |
SOWG vs HIMS vs SMPL vs NOMD vs JBSS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Sow Good Inc. (SOWG) | 100 | 2.2 | -97.8% |
| Hims & Hers Health,… (HIMS) | 100 | 284.6 | +184.6% |
| The Simply Good Foo… (SMPL) | 100 | 72.0 | -28.0% |
| Nomad Foods Limited (NOMD) | 100 | 44.6 | -55.4% |
| John B. Sanfilippo … (JBSS) | 100 | 89.7 | -10.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SOWG vs HIMS vs SMPL vs NOMD vs JBSS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, SOWG doesn't own a clear edge in any measured category.
HIMS ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 59.0%, EPS growth -3.8%, 3Y rev CAGR 64.5%
- 161.9% 10Y total return vs JBSS's 101.1%
- 59.0% revenue growth vs SOWG's -100.0%
SMPL is the clearest fit if your priority is sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.38, Low D/E 16.8%, current ratio 3.64x
- PEG 0.31 vs JBSS's 8.42
- 6.3% margin vs SOWG's -4.2%
NOMD carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 2 yrs, beta 0.07, yield 7.1%
- Beta 0.07, yield 7.1%, current ratio 1.07x
- Lower P/E (6.2x vs 11.9x)
- Beta 0.07 vs HIMS's 2.40, lower leverage
JBSS is the #2 pick in this set and the best alternative if momentum and efficiency is your priority.
- +39.3% vs SOWG's -87.0%
- 11.7% ROA vs SOWG's -123.1%, ROIC 15.2% vs -21.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 59.0% revenue growth vs SOWG's -100.0% | |
| Value | Lower P/E (6.2x vs 11.9x) | |
| Quality / Margins | 6.3% margin vs SOWG's -4.2% | |
| Stability / Safety | Beta 0.07 vs HIMS's 2.40, lower leverage | |
| Dividends | 7.1% yield, 2-year raise streak, vs JBSS's 2.7%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +39.3% vs SOWG's -87.0% | |
| Efficiency (ROA) | 11.7% ROA vs SOWG's -123.1%, ROIC 15.2% vs -21.5% |
SOWG vs HIMS vs SMPL vs NOMD vs JBSS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
SOWG vs HIMS vs SMPL vs NOMD vs JBSS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NOMD leads in 2 of 6 categories
SMPL leads 1 • JBSS leads 1 • HIMS leads 1 • SOWG leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SMPL leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NOMD and SOWG operate at a comparable scale, with $3.0B and $0 in trailing revenue. Profitability is closely matched — net margins range from 6.3% (SMPL) to 4.5% (NOMD). On growth, HIMS holds the edge at +28.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $2.3B | $1.4B | $3.0B | $1.1B |
| EBITDAEarnings before interest/tax | -$5M | $164M | $231M | $435M | $127M |
| Net IncomeAfter-tax profit | -$41M | $128M | $91M | $137M | $70M |
| Free Cash FlowCash after capex | -$5M | $73M | $174M | $252M | $33M |
| Gross MarginGross profit ÷ Revenue | — | +69.7% | +34.0% | +27.1% | +19.1% |
| Operating MarginEBIT ÷ Revenue | — | +4.6% | +14.4% | +10.7% | +8.9% |
| Net MarginNet income ÷ Revenue | — | +5.5% | +6.3% | +4.5% | +6.2% |
| FCF MarginFCF ÷ Revenue | — | +3.1% | +12.0% | +8.3% | +2.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -5.3% | +28.4% | -0.3% | -2.6% | +4.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.9% | -27.3% | -31.6% | -123.1% | +31.9% |
Valuation Metrics
NOMD leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 9.5x trailing earnings, NOMD trades at a 81% valuation discount to HIMS's 50.3x P/E. Adjusting for growth (PEG ratio), SMPL offers better value at 0.51x vs JBSS's 11.02x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1M | $6.6B | $1.2B | $1.4B | $913M |
| Enterprise ValueMkt cap + debt − cash | $1M | $7.5B | $1.4B | $3.7B | $1.0B |
| Trailing P/EPrice ÷ TTM EPS | -0.02x | 50.32x | 12.20x | 9.46x | 15.53x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 58.29x | 7.39x | 6.23x | 11.87x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.51x | — | 11.02x |
| EV / EBITDAEnterprise value multiple | — | 42.68x | 5.97x | 7.34x | 8.73x |
| Price / SalesMarket cap ÷ Revenue | — | 2.82x | 0.86x | 0.40x | 0.82x |
| Price / BookPrice ÷ Book value/share | — | 12.25x | 0.70x | 0.52x | 2.54x |
| Price / FCFMarket cap ÷ FCF | — | 89.61x | 7.86x | 4.85x | — |
Profitability & Efficiency
JBSS leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
HIMS delivers a 23.7% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-2 for SOWG. SMPL carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.07x. On the Piotroski fundamental quality scale (0–9), SMPL scores 5/9 vs SOWG's 1/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.1% | +23.7% | +5.2% | +5.3% | +19.5% |
| ROA (TTM)Return on assets | -123.1% | +6.0% | +3.7% | +2.2% | +11.7% |
| ROICReturn on invested capital | -21.5% | +10.7% | +8.1% | +5.5% | +15.2% |
| ROCEReturn on capital employed | -29.4% | +10.9% | +9.4% | +6.2% | +20.4% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 4 | 5 | 4 | 2 |
| Debt / EquityFinancial leverage | — | 2.07x | 0.17x | 0.92x | 0.28x |
| Net DebtTotal debt minus cash | $95,146 | $892M | $206M | $2.0B | $102M |
| Cash & Equiv.Liquid assets | $1M | $229M | $98M | $325M | $585,000 |
| Total DebtShort + long-term debt | $2M | $1.1B | $304M | $2.3B | $102M |
| Interest CoverageEBIT ÷ Interest expense | -33.23x | — | 6.77x | 2.52x | 26.02x |
Total Returns (Dividends Reinvested)
HIMS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HIMS five years ago would be worth $23,764 today (with dividends reinvested), compared to $151 for SOWG. Over the past 12 months, JBSS leads with a +39.3% total return vs SOWG's -87.0%. The 3-year compound annual growth rate (CAGR) favors HIMS at 29.4% vs SOWG's -73.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -76.6% | -23.2% | -36.4% | -15.4% | +14.1% |
| 1-Year ReturnPast 12 months | -87.0% | -51.0% | -64.8% | -43.5% | +39.3% |
| 3-Year ReturnCumulative with dividends | -98.1% | +116.6% | -67.8% | -40.3% | -22.9% |
| 5-Year ReturnCumulative with dividends | -98.5% | +137.6% | -64.3% | -59.7% | +4.0% |
| 10-Year ReturnCumulative with dividends | -99.6% | +161.9% | +3.7% | +40.1% | +101.1% |
| CAGR (3Y)Annualised 3-year return | -73.3% | +29.4% | -31.5% | -15.8% | -8.3% |
Risk & Volatility
Evenly matched — NOMD and JBSS each lead in 1 of 2 comparable metrics.
Risk & Volatility
NOMD is the less volatile stock with a 0.07 beta — it tends to amplify market swings less than HIMS's 2.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JBSS currently trades 91.7% from its 52-week high vs SOWG's 3.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.07x | 2.48x | 0.34x | 0.08x | 0.32x |
| 52-Week HighHighest price in past year | $31.80 | $70.43 | $36.92 | $19.71 | $85.15 |
| 52-Week LowLowest price in past year | $0.70 | $13.74 | $10.21 | $9.17 | $58.47 |
| % of 52W HighCurrent price vs 52-week peak | +3.8% | +36.4% | +33.7% | +51.3% | +91.7% |
| RSI (14)Momentum oscillator 0–100 | 21.2 | 54.5 | 42.9 | 58.6 | 49.2 |
| Avg Volume (50D)Average daily shares traded | 374K | 34.9M | 2.8M | 1.6M | 80K |
Analyst Outlook
NOMD leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HIMS as "Hold", SMPL as "Buy", NOMD as "Buy", JBSS as "Buy". Consensus price targets imply 47.3% upside for SMPL (target: $18) vs 2.1% for HIMS (target: $26). For income investors, NOMD offers the higher dividend yield at 7.06% vs JBSS's 2.67%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $26.20 | $18.33 | $13.50 | — |
| # AnalystsCovering analysts | — | 19 | 24 | 13 | 2 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +7.1% | +2.7% |
| Dividend StreakConsecutive years of raises | — | — | — | 2 | 0 |
| Dividend / ShareAnnual DPS | — | — | — | $0.61 | $2.08 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.4% | +4.1% | +16.5% | +0.1% |
NOMD leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). SMPL leads in 1 (Income & Cash Flow). 1 tied.
SOWG vs HIMS vs SMPL vs NOMD vs JBSS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SOWG or HIMS or SMPL or NOMD or JBSS a better buy right now?
For growth investors, Hims & Hers Health, Inc.
(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -100. 0% for Sow Good Inc. (SOWG). Nomad Foods Limited (NOMD) offers the better valuation at 9. 5x trailing P/E (6. 2x forward), making it the more compelling value choice. Analysts rate The Simply Good Foods Company (SMPL) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SOWG or HIMS or SMPL or NOMD or JBSS?
On trailing P/E, Nomad Foods Limited (NOMD) is the cheapest at 9.
5x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, Nomad Foods Limited is actually cheaper at 6. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Simply Good Foods Company wins at 0. 31x versus John B. Sanfilippo & Son, Inc. 's 8. 42x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SOWG or HIMS or SMPL or NOMD or JBSS?
Over the past 5 years, Hims & Hers Health, Inc.
(HIMS) delivered a total return of +137. 6%, compared to -98. 5% for Sow Good Inc. (SOWG). Over 10 years, the gap is even starker: HIMS returned +188. 5% versus SOWG's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SOWG or HIMS or SMPL or NOMD or JBSS?
By beta (market sensitivity over 5 years), Nomad Foods Limited (NOMD) is the lower-risk stock at 0.
08β versus Hims & Hers Health, Inc. 's 2. 48β — meaning HIMS is approximately 3142% more volatile than NOMD relative to the S&P 500. On balance sheet safety, The Simply Good Foods Company (SMPL) carries a lower debt/equity ratio of 17% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SOWG or HIMS or SMPL or NOMD or JBSS?
By revenue growth (latest reported year), Hims & Hers Health, Inc.
(HIMS) is pulling ahead at 59. 0% versus -100. 0% for Sow Good Inc. (SOWG). On earnings-per-share growth, the picture is similar: John B. Sanfilippo & Son, Inc. grew EPS -2. 3% year-over-year, compared to -760. 0% for Sow Good Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SOWG or HIMS or SMPL or NOMD or JBSS?
The Simply Good Foods Company (SMPL) is the more profitable company, earning 7.
1% net margin versus 0. 0% for Sow Good Inc. — meaning it keeps 7. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMPL leads at 15. 1% versus 0. 0% for SOWG. At the gross margin level — before operating expenses — HIMS leads at 59. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SOWG or HIMS or SMPL or NOMD or JBSS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, The Simply Good Foods Company (SMPL) is the more undervalued stock at a PEG of 0. 31x versus John B. Sanfilippo & Son, Inc. 's 8. 42x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Nomad Foods Limited (NOMD) trades at 6. 2x forward P/E versus 58. 3x for Hims & Hers Health, Inc. — 52. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SMPL: 47. 3% to $18. 33.
08Which pays a better dividend — SOWG or HIMS or SMPL or NOMD or JBSS?
In this comparison, NOMD (7.
1% yield), JBSS (2. 7% yield) pay a dividend. SOWG, HIMS, SMPL do not pay a meaningful dividend and should not be held primarily for income.
09Is SOWG or HIMS or SMPL or NOMD or JBSS better for a retirement portfolio?
For long-horizon retirement investors, Nomad Foods Limited (NOMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
08), 7. 1% yield). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 48 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NOMD: +31. 8%, HIMS: +188. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SOWG and HIMS and SMPL and NOMD and JBSS?
These companies operate in different sectors (SOWG (Consumer Defensive) and HIMS (Healthcare) and SMPL (Consumer Defensive) and NOMD (Consumer Defensive) and JBSS (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SOWG is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock; SMPL is a small-cap deep-value stock; NOMD is a small-cap deep-value stock; JBSS is a small-cap deep-value stock. NOMD, JBSS pay a dividend while SOWG, HIMS, SMPL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.